FY21 Result: A solid FY21 result for CSL booking a ~3% beat at the profit line, a record dividend to boot however guidance of NPAT for FY22 of $2.15bn-$2.25bn was below the $2.32bn the market had already penciled in. CSL have a history of under promising and over delivering, however the outlook should put a cap on the stock in the near term.
MM is neutral CSL around $300
Add To Hit List
